LMO2 plays differential roles in trophoblast subtypes and is associated with preeclampsia

Biochem Biophys Res Commun. 2022 May 14:604:43-50. doi: 10.1016/j.bbrc.2022.03.033. Epub 2022 Mar 9.

Abstract

Preeclampsia (PE) is a common obstetric disease caused by placenta development abnormality, typically characterized as inadequate trophoblast invasion and spiral artery remodeling. In this study, we found that LMO2 level was decreased in both cytotrophoblast (CTB) and interstitial extravillous trophoblast (iEVT) in human PE placentas, and LMO2 selectively promoted cell migration in iEVT derived HTR-8/SVneo cells whereas increased proliferation in CTB derived JEG-3 cells. In mechanism, LMO2 interacted with NCKAP1, leading to destruction of WAVE regulatory complex and increased lamellipodia formation in HTR-8/SVneo cells, whereas interacted with β-catenin and up-regulated a number of core Wnt/Hippo pathway target genes in JEG-3 cells. This study revealed the differentially functional patterns of LMO2 in different trophoblast subtypes, and suggested LMO2 as a novel target for PE prediction, prevention and treatment in clinical.

Keywords: Hippo pathway; LMO2; Preeclampsia; Trophoblast; WAVE complex; Wnt pathway.

MeSH terms

  • Adaptor Proteins, Signal Transducing / genetics
  • Adaptor Proteins, Signal Transducing / metabolism
  • Cell Line, Tumor
  • Cell Movement
  • Female
  • Humans
  • LIM Domain Proteins / genetics
  • LIM Domain Proteins / metabolism
  • Placenta / metabolism
  • Placentation
  • Pre-Eclampsia* / metabolism
  • Pregnancy
  • Proto-Oncogene Proteins / metabolism
  • Trophoblasts* / metabolism

Substances

  • Adaptor Proteins, Signal Transducing
  • LIM Domain Proteins
  • LMO2 protein, human
  • Proto-Oncogene Proteins